Advertisement

Hand Function pp 201-207 | Cite as

Hand Function in Metabolic Disorders: Hemodialysis, Diabetes Mellitus, and Gout

  • Feray SoyupekEmail author
  • Selami Akkuş
Chapter

Abstract

Metabolic disease including chronic renal failure, gout, and diabetes mellitus impair hand function via occurring musculoskeletal abnormalities and hemodynamic, vascular, or neurological dysfunctions. Carpal tunnel syndrome (CTS), destructive arthropathy, bone cyst, bone erosions, and tendon abnormalities are seen in patients receiving hemodialysis. Diabetes mellitus is associated with an increased incidence of functional disability. The complications of diabetes mellitus seen in the hand are diabetic stiff hand syndrome, Dupuytren’s disease, CTS, trigger finger, Complex Regional Pain Syndrome type-1, and neuropathy. Hand involvements of the patients with gout are monosodium urate crystal deposition in tendon, joints, and nerve. Tophi lead to destructive arthropathy and present on the fingers and the volar surface of the hands. Muscle strength test, range of motion evaluation, hand dexterity, and daily activity tests could be assessed in those patients. In this chapter, the musculoskeletal and the other involvements of the hand were mentioned. Additionally, the tests evaluating hand functions and index which were used for evaluating hand disability were reviewed.

Keywords

Carpal Tunnel Syndrome Tendon Rupture Handgrip Strength Hand Function Pinch Strength 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Kessler M, Netter P, Azoulay E, Mayeux D, Péré P, Gaucher A. Dialysis-associated arthropathy: a multicenter survey of 171 patients receiving haemodialysis for over 10 years. Br J Rheumatol. 1992;31:157–62.PubMedCrossRefGoogle Scholar
  2. 2.
    Kay J. β2 microglobulin amyloidosis. Amyloid. 1997;4:187–211.CrossRefGoogle Scholar
  3. 3.
    Kay J, Bardin T. Osteoarticular disorders of renal origin: disease related and iatrogenic. Baillieres Best Pract Res Clin Rheumatol. 2000;14(2):285–305.PubMedCrossRefGoogle Scholar
  4. 4.
    Jadoul M, Garbar C, Noël H, Sennesael J, Vanholder R, Bernaert P, Rorive G, Hanique G, van Ypersele de Strihou C. Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study. Kidney Int. 1997;51(6):1928–32.PubMedCrossRefGoogle Scholar
  5. 5.
    Zingraff J, DiGiulio S, Hafes S. Carpal tunnel syndrome in hemodialysis patients. Kidney Int. 1980;18:801–2.Google Scholar
  6. 6.
    Benz RL, Siegfried JW, Teehan BP. Carpal tunnel syndrome in dialysis patients: comparison between continuous ambulatory peritoneal dialysis and hemodialysis populations. Am J Kidney Dis. 1988;11(6):473–6.PubMedGoogle Scholar
  7. 7.
    Martinez J, Forts P, Falgás J, Martinez E, Mascort I, Plans A, Rotellar E. Carpal tunnel syndrome and chronic hemodialysis. Am J Nephrol. 1985;5(6):476.PubMedCrossRefGoogle Scholar
  8. 8.
    Kumar S, Trivedi HL, Smith EK. Carpal tunnel syndrome: a complication of arteriovenous fistula in hemodialysis patients. Can Med Assoc J. 1975;113:1070–2.PubMedCentralPubMedGoogle Scholar
  9. 9.
    Schwarz A, Keller F, Seyfert S, Pöll W, Molzahn M, Distler A. Carpal tunnel syndrome: a major complication in long-term hemodialysis patients. Clin Nephrol. 1984;22:133–7.PubMedGoogle Scholar
  10. 10.
    Namazi H, Majd Z. Carpal tunnel syndrome in patients who are receiving long-term renal hemodialysis. Arch Orthop Trauma Surg. 2007;127(8):725–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Flipo RM, Le Loet X, Siame JL, et al. Destructive arthropathy of the hand in patients treated by long term hemodialysis. Seven cases with pathologic examination. Rev Rheum Engl Ed. 1995;62:241.Google Scholar
  12. 12.
    Kurer MH, Baillod RA, Madgwick JC. Musculoskeletal manifestations of amyloidosis. A review of 83 patients on haemodialysis for at least 10 years. J Bone Joint Surg Br. 1991;73(2):271–6.PubMedGoogle Scholar
  13. 13.
    Kuntz D, Naveau B, Bardin T, Drueke T, Treves R, Dryll A. Destructive spondylarthropathy in hemodialyzed patients. A new syndrome. Arthritis Rheum. 1984;27(4):369–75.PubMedCrossRefGoogle Scholar
  14. 14.
    Bindi P, Lavaud S, Bernieh B, Toupance O, Chanard J. Early and late occurrences of destructive spondyloarthropathy in haemodialysed patients. Nephrol Dial Transplant. 1990;5(3):199–203.PubMedCrossRefGoogle Scholar
  15. 15.
    Maruyama H, Gejyo F, Arakawa M. Clinical studies of destructive spondyloarthropathy in long-term hemodialysis patients. Nephron. 1992;61(1):37–44.PubMedCrossRefGoogle Scholar
  16. 16.
    Ross LV, Ross GJ, Mesgarzadeh M, Edmonds PR, Bonakdarpour A. Hemodialysis-related amyloidomas of bone. Radiology. 1991;178(1):263–5.PubMedGoogle Scholar
  17. 17.
    Sargent MA, Fleming SJ, Chattopadhyay C, Ackrill P, Sambrook P. Bone cysts and hemodialysis-related amyloidosis. Clin Radiol. 1989;40:277–81.PubMedCrossRefGoogle Scholar
  18. 18.
    DiRaimondo CR, Casey TT, DiRaimondo CV, Stone WJ. Pathologic fractures associated with idiopathic amyloidosis of bone in hemodialysis patients. Nephron. 1986;43:22–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Fitzpatrick DC, Jebson PJ, Madey SM, Steyers CM. Upper extremity musculoskeletal manifestations of dialysis-associated amyloidosis. Iowa Orthop J. 1996;16:135–8.PubMedCentralPubMedGoogle Scholar
  20. 20.
    Lindstedt E, Westling H. Effects of antebrachial Cimino-Brescia arteriovenous fistula on the local circulation in the hand. Scand J Urol Nephrol. 1975;9:119–24.PubMedCrossRefGoogle Scholar
  21. 21.
    Duruöz MT, Cerrahoglu L, Dincer-Turhan Y, Kürsat S. Hand function assessment in patients receiving haemodialysis. Swiss Med Wkly. 2003;133(31–32):433–8.PubMedGoogle Scholar
  22. 22.
    Cuppari L, Avesani CM, Mendonça COG. Doenças Renais. In: Cuppari L, editor. Guias de Medicina ambulatorial e hospitalar. Unifesp/Escola Paulista de Medicina, Nutrição. 2nd ed. Manole: São Paulo, BR; 2005. p. 189–220.Google Scholar
  23. 23.
    Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Treviño-Becerra A, Wanner C. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Mathiowetz V, Weber K, Volland G, Kashman N. Reliability and validity of grip and pinch strength evaluations. J Hand Surg [Am]. 1984;9A:222–6.CrossRefGoogle Scholar
  25. 25.
    Buddenberg LA, Davis C. Test- retest reliability of the Purdue pegboard test. Am J Occup Ther. 2000;54(5):555–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Sollerman C. Assessment of grip function: evaluation of a new test method. Doctoral dissertation. Goteborg, Sweden: University of Goteborg; 1980.Google Scholar
  27. 27.
    Tander B, Akpolat T, Durmus D, Canturk F. Evaluation of hand functions in hemodialysis patients. Ren Fail. 2007;29(4):477–80.PubMedCrossRefGoogle Scholar
  28. 28.
    Chazot C, Chazot I, Charra B, Terrat JC, Vanel T, Calemard E, Ruffet M, Laurent G. Functional study of hands among patients dialysed for more than 10 years. Nephrol Dial Transplant. 1993;8(4):347–51.PubMedGoogle Scholar
  29. 29.
    Branz NR, Newton RA. Hand function in patients on maintenance hemodialysis. Phys Ther. 1988;68(7):1092–7.PubMedGoogle Scholar
  30. 30.
    Limaye V, Frankham A, Disney A, Pile K. Evaluation of hand function in patients undergoing long term haemodialysis. Ann Rheum Dis. 2001;60(3):278–80.PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Duruoz MT, Poiraudeau S, Fermanian J, et al. Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. J Rheumatol. 1996;23:1167–72.PubMedGoogle Scholar
  32. 32.
    Gregg EW, Mangione CM, Cauley JA, Thompson TJ, Schwartz AV, Ensrud KE, Nevitt MC. Diabetes and incidence of functional disability in older women. Diabetes Care. 2002;25:61–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Guralnick JM, La Croix AZ, Abbott RD, Berkman LF, Satterfield S, Evans DA, Wallace RB. Maintaining mobility in late life I. Demographic characteristics and chronic conditions. Am J Epidemiol. 1993;137:845–57.Google Scholar
  34. 34.
    Pinsky JL, Jette AM, Branch LC, Kannel WB, Feinlab M. The Framingham disability study: relationship of various coronary heart disease manifestations to disability in order persons living in the community. Am J Public Health. 1990;80:1363–8.PubMedCentralPubMedCrossRefGoogle Scholar
  35. 35.
    Clark DO, Stump TE, Wolinsky FD. Predictors of onset and recovery from mobility difficulty among adults aged 51–61 years. Am J Epidemiol. 1998;148:63–71.PubMedCrossRefGoogle Scholar
  36. 36.
    Lee PP, Spitzer K, Hays RD. The impact of blurred vision on functioning and well-being. Ophthalmology. 1997;104:390–6.PubMedCrossRefGoogle Scholar
  37. 37.
    Resnick HE, Vinik AI, Schwartz AV, Leveille SG, Brancati FL, Balfour J, Guralnik JM. Independent effects of peripheral nerve dysfunction on lower extremity physical function in older age: the Women’s Health and Aging Study. Diabetes Care. 2000;13:1642–7.CrossRefGoogle Scholar
  38. 38.
    Friend LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA. Cardiovascular Health Study Collaborative Research Group. Frailty in olderadults: evidence for a phenotype. J Gerontol Med Sci. 2001;56A:M146–56.CrossRefGoogle Scholar
  39. 39.
    Ardic F, Soyupek F, Kahraman Y, Yorgancioglu R. The musculoskeletal complications seen in type II diabetics: predominance of hand involvement. Clin Rheumatol. 2003;22(3):229–33.PubMedCrossRefGoogle Scholar
  40. 40.
    Arkkila PET, Kantola IM, Viikari JSA, Ronnemaa T, Vähätalo MA. Dupuytren’s disease in type-1 diabetic patients: a five-year prospective study. Clin Exp Rheumatol. 1996;14:59–65.PubMedGoogle Scholar
  41. 41.
    Cagliero E, Apruzzese W, Perlmutter CS, Nathan DM. Musculoskeletal disorders of the hand and shoulders in patients with diabetes mellitus. Am J Med. 2002;112:487–90.PubMedCrossRefGoogle Scholar
  42. 42.
    Chammas M, Bousquet P, Renard E, Poirier JL, Jaffiol C, Allieu Y. Dupuytren’s disease, carpal tunnel syndrome, trigger finger, and diabetes mellitus. J Hand Surg [Am]. 1995;20:109–15.CrossRefGoogle Scholar
  43. 43.
    Jennings AM, Milner PC, Ward JD. Hand abnormalities are associated with the complications of diabetes in type 2 diabetes. Diabet Med. 1989;6(1):43–7.PubMedCrossRefGoogle Scholar
  44. 44.
    Cetinus E, Buyukbese MA, Uzel M, Ekerbicer H, Karaoguz A. Hand grip strength in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2005;70(3):278–86.PubMedCrossRefGoogle Scholar
  45. 45.
    Savas S, Koroglu BK, Koyuncuoglu HR, Uzar E, Celik H, Tamer NM. The effects of the diabetes related soft tissue hand lesions and the reduced hand strength on functional disability of hand in type 2 diabetic patients. Diabetes Res Clin Pract. 2007;77(1):77–83.PubMedCrossRefGoogle Scholar
  46. 46.
    American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2008;31 Suppl 1:S12–54.CrossRefGoogle Scholar
  47. 47.
    Dutch Association of Neurology (NVN), Dutch Association of Clinical Neurophysiology (NVKNF). Guideline Polyneuropathy of the Dutch Institute for Healthcare Improvement (CBO). Alphen a/d Rijn, The Netherlands: van Zuiden; 2005. p. 6.Google Scholar
  48. 48.
    NHS National Institute for Clinical Excellence (NICE). Type 2 diabetes prevention and management of foot problems, Clinical Guideline 10. London, UK: National Institute for Clinical Excellence (NICE); 2004.Google Scholar
  49. 49.
    Mueller MJ. Identifying patients with diabetes mellitus who are at risk for lower-extremity complications: use of Semmes-Weinstein monofilaments. Phys Ther. 1996;76(1):68–71.PubMedGoogle Scholar
  50. 50.
    Valk GD, de Sonnaville JJ, van Houtum WH, Heine RJ, van Eijk JT, Bouter LM, Bertelsmann FW. The assessment of diabetic polyneuropathy in daily clinical practice: reproducibility and validity of Semmes Weinstein monofilaments examination and clinical neurological examination. Muscle Nerve. 1997;20(1):116–1.PubMedCrossRefGoogle Scholar
  51. 51.
    Dros J, Wewerinke A, Bindels PJ, van Weert HC. Accuracy of monofilament testing to diagnose peripheral neuropathy: a systematic review. Ann Fam Med. 2009;7(6):555–8.PubMedCentralPubMedCrossRefGoogle Scholar
  52. 52.
    Travieso D, Lederman SJ. Assessing subclinical tactual deficits in the hand function of diabetic blind persons at risk for peripheral neuropathy. Arch Phys Med Rehabil. 2007;88(12):1662–72.PubMedCrossRefGoogle Scholar
  53. 53.
    Turan Y, Duruöz MT, Aksakalli E, Gürgan A. Validation of Duruöz hand index for diabetic hand dysfunction. J Investig Med. 2009;57(8):887–91.PubMedGoogle Scholar
  54. 54.
    Chui CH, Lee JY. Diagnostic dilemmas in unusual presentations of gout. Aust Fam Physician. 2007;36(11):931–4.PubMedGoogle Scholar
  55. 55.
    Redmond CL, Bain GI, Laslett LL, McNeil JD. Hand syndromes associated with diabetes: impairments and obesity predict disability. J Rheumatol. 2009;36(12):2766–71.PubMedCrossRefGoogle Scholar
  56. 56.
    Dalbeth N, Collis J, Gregory K, Clark B, Robinson E, McQueen FM. Tophaceous joint disease strongly predicts hand function in patients with gout. Rheumatology (Oxford). 2007;46(12):1804–7.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of Physical Medicine and RehabilitationSuleyman Demirel University, School of MedicineIspartaTurkey
  2. 2.Department of Physical Medicine and RehabilitationSchool of Medicine, Yildirim Beyazit UniversityAnkaraTurkey

Personalised recommendations